Skip to main content
    V

    Vanda Pharmaceuticals Inc (VNDA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.81
    -0.18 (-4.51%)

    Market Cap: $241.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vanda Pharmaceuticals Inc (VNDA) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Vanda Pharmaceuticals (VNDA) trades at 1.0x sales and 1.2x book value. Its P/S of 1.0x is below its 5-year median of 1.5x. Its forward P/E is 103.1x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E103.1x
    Price to sales1.0x
    Price to book1.2x
    PEGN/A
    FCF yield-60.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 58.3% below 2.4x and its P/B is 20.0% below 1.5x.

    MultipleCurrent5-year median10-year median
    P/S1.0x1.5x2.4x
    P/B1.2x0.7x1.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 6 of the 10 year ends shown that have a P/E, its P/E ranged from 7.0x in 2019 to 80.5x in 2023. 2023 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$8.82N/A2.4x1.6x
    2024$4.79N/A1.4x0.5x
    2023$4.2280.5x1.3x0.4x
    2022$7.3961.6x1.6x0.8x
    2021$15.6927.1x3.3x1.8x
    2020$13.1425.8x2.9x1.6x
    2019$16.417.0x3.9x2.2x
    2018$26.1335.3x7.0x5.2x
    2017$15.20N/A4.1x5.2x
    2016$15.95N/A4.7x5.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About VNDA

    What is VNDA's forward P/E ratio?

    Vanda Pharmaceuticals has a forward P/E ratio of 103.1x.

    Is VNDA stock overvalued?

    GNG's valuation label for VNDA is Undervalued.

    What is VNDA's price to sales ratio?

    Vanda Pharmaceuticals has a price to sales ratio of 1.0x.